3,4-dihydroxyphenylacetic acid has been researched along with mazindol in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (29.41) | 18.7374 |
| 1990's | 8 (47.06) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuller, RW; Snoddy, HD | 2 |
| Hashim, A; Lajtha, A; Sershen, H; Wiener, HL | 1 |
| Glynn, GE; Yamamoto, BK | 1 |
| Cubeddu, LX; Parker, EM | 1 |
| Fuller, RW; Hemrick-Luecke, SK; Snoddy, HD | 1 |
| Ikawa, K; Kaneno, S; Toru, M; Watanabe, A | 1 |
| Ikawa, K; Kaneno, S; Motohashi, N; Watanabe, A | 1 |
| Donnan, GA; Howells, DW; Liberatore, GT; Wong, JY | 1 |
| Ali, SF; Itzhak, Y | 1 |
| Hashitani, T; Kumazaki, M; Mizukawa, K; Nishino, H | 1 |
| Beal, MF; Hyman, BT; Klockgether, T; Liao, AW; Martinou, JC; Matthews, RT; Penney, JB; Schulz, JB; Yang, L | 1 |
| Ali, SF; Itzhak, Y; Martin, JL | 1 |
| Demaria, JE; Fekete, MI; Freeman, ME; Lerant, AA; Levenson, CW; Nagy, GM | 1 |
| Boulay, D; Costentin, J; Leroux-Nicollet, I; Naudon, L | 1 |
| Albers, DS; Augood, SJ; Breakefield, XO; Hollingsworth, Z; Leung, J; Standaert, DG; Yang, L | 1 |
| Copeland, BJ; Hadjiconstantinou, M; Neff, NH | 1 |
17 other study(ies) available for 3,4-dihydroxyphenylacetic acid and mazindol
| Article | Year |
|---|---|
Inability of methylphenidate or mazindol to prevent the lowering of 3,4-dihydroxyphenylacetic acid in rat brain by amphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamines; Animals; Brain Chemistry; Drug Interactions; Humans; Indoles; Male; Mazindol; Methylphenidate; p-Chloroamphetamine; Phenylacetates; Rats; Reserpine; Stereotyped Behavior | 1979 |
Effect of mazindol on brain dopamine turnover in spiperone-treated rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Butyrophenones; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Indoles; Male; Mazindol; Naphthyridines; Rats; Spiperone | 1979 |
Chronic L-deprenyl-induced up-regulation of the dopamine uptake carrier.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Catecholamines; Corpus Striatum; Dopamine; Male; Mazindol; Mice; Mice, Inbred BALB C; Monoamine Oxidase; Phenethylamines; Receptors, Dopamine; Selegiline | 1989 |
In vivo neurochemical and anatomical heterogeneity of the dopamine uptake system in the rat caudate putamen.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Caudate Nucleus; Dopamine; Electrochemistry; Homovanillic Acid; Indoles; Male; Mazindol; Neurotransmitter Uptake Inhibitors; Nomifensine; Putamen; Rats; Rats, Inbred Strains | 1989 |
Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Corpus Striatum; Dopamine; Indoles; Kinetics; Male; Mazindol; Membranes; Octopamine; Phenethylamines; Rabbits; Time Factors | 1988 |
Fluoxetine at anorectic doses does not have properties of a dopamine uptake inhibitor.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Appetite Depressants; Brain Chemistry; Dopamine; Dopamine Uptake Inhibitors; Fluoxetine; Homovanillic Acid; Injections, Intraventricular; Male; Mazindol; Neostriatum; Oxidopamine; Rats; Rats, Sprague-Dawley | 1994 |
Modulation of [3H]mazindol binding sites in rat striatum by dopaminergic agents.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Methyltyrosine; Animals; Binding Sites; Dopamine; Dopamine Agents; Homovanillic Acid; Levodopa; Male; Mazindol; Methyltyrosines; Neostriatum; Neurotransmitter Uptake Inhibitors; Piperazines; Rats; Rats, Wistar; Receptors, Presynaptic; Tyrosine 3-Monooxygenase | 1993 |
The effect of repeated administration of methamphetamine on dopamine uptake sites in rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Binding Sites; Corpus Striatum; Dopamine; Homovanillic Acid; Injections, Intraperitoneal; Mazindol; Methamphetamine; Osmolar Concentration; Rats; Rats, Wistar; Time Factors | 1994 |
Dopaminergic responses to striatal damage.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Brain Tissue Transplantation; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Functional Laterality; Homovanillic Acid; Humans; Male; Mazindol; Mice; Mice, Inbred C57BL; Parkinson Disease; Reference Values; Synapses; Time Factors; Tyrosine 3-Monooxygenase | 1996 |
The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Carrier Proteins; Cell Membrane; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Enzyme Inhibitors; Homovanillic Acid; Indazoles; Kinetics; Male; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Mice; Nerve Tissue Proteins; Neurons; Neurotoxins; Nitric Oxide Synthase; Reference Values | 1996 |
Dopamine metabolism in the striatum of hemiparkinsonian model rats with dopaminergic grafts.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Autoradiography; Brain Tissue Transplantation; Carrier Proteins; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Fetal Tissue Transplantation; Functional Laterality; Haloperidol; Homovanillic Acid; Kinetics; Levodopa; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Mesencephalon; Methamphetamine; Microdialysis; Motor Activity; Nerve Tissue Proteins; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Wistar; Rotation; Tritium; Tyrosine 3-Monooxygenase | 1998 |
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Apoptosis; Brain Chemistry; Caspase 2; Caspase Inhibitors; Caspases; Dopamine; Dopamine Agents; Dopamine Uptake Inhibitors; Female; Free Radicals; Gene Expression; Homovanillic Acid; Injections, Intraperitoneal; Male; Mazindol; Mice; Mice, Transgenic; MPTP Poisoning; Neurons; Neurotoxins; Oxidative Stress; Pregnancy; Proto-Oncogene Proteins c-bcl-2; Radioligand Assay; Tritium; Tyrosine | 1998 |
Methamphetamine- and 1-methyl-4-phenyl- 1,2,3, 6-tetrahydropyridine-induced dopaminergic neurotoxicity in inducible nitric oxide synthase-deficient mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Temperature; Carrier Proteins; Dopamine; Dopamine Plasma Membrane Transport Proteins; Fever; Gene Deletion; Homovanillic Acid; Male; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; Neostriatum; Nerve Tissue Proteins; Neurons; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Time Factors | 1999 |
Dopamine transporters participate in the physiological regulation of prolactin.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Carrier Proteins; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Estradiol; Female; Hypothalamo-Hypophyseal System; Immunohistochemistry; Mazindol; Median Eminence; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neurosecretory Systems; Prolactin; Rats; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase | 2000 |
Decreased densities of dopamine and serotonin transporters and of vesicular monoamine transporter 2 in severely kainic acid lesioned subregions of the striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Carrier Proteins; Chromatography, High Pressure Liquid; Citalopram; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Excitatory Amino Acid Agonists; Homovanillic Acid; Hydroxyindoleacetic Acid; Kainic Acid; Male; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neuropeptides; Radioligand Assay; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tetrabenazine; Tritium; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2001 |
Dopamine transmission in DYT1 dystonia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Autoradiography; Basal Ganglia; Benzamides; Benzazepines; Binding Sites; Carrier Proteins; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dystonia; Family Health; Homovanillic Acid; Humans; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Molecular Chaperones; Neuropeptides; Synaptic Transmission; Tetrabenazine; Tritium; Vesicular Biogenic Amine Transport Proteins | 2004 |
Enhanced dopamine uptake in the striatum following repeated restraint stress.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenalectomy; Animals; Behavior, Animal; Biogenic Amines; Chromatography, High Pressure Liquid; Corpus Striatum; Corticosterone; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Electrochemistry; Haloperidol; Hormone Antagonists; Male; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mifepristone; Nerve Tissue Proteins; Protein Binding; Quinpirole; Restraint, Physical; RNA, Messenger; Stress, Physiological; Time Factors; Tritium; Tyrosine | 2005 |